Plaque Psoriasis Market Size, Epidemiology, Leading Companies, Drugs and Competitive Analysis by DelveInsight
(Albany, US) DelveInsight has launched a new report on "Plaque Psoriasis - Market Insights, Epidemiology, and Market Forecast-2030".
DelveInsight's "Plaque
Psoriasis - Market Insights, Epidemiology, and Market Forecast-2030" report
delivers an in-depth understanding of the Plaque Psoriasis, historical and
forecasted epidemiology as well as the Plaque Psoriasis market trends in the
United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and
Japan.
·
According to National Psoriasis Foundation
(NPF), more than 8 million Americans have psoriasis. Plaque psoriasis is the
most common form of the disease, affecting 80 percent of those with psoriasis.
·
In U.S., the prevalence of Psoriasis is
estimated to be 0.6 to 4.8%.
·
125 million people worldwide which is about 2 to
3 percent of the total population have psoriasis, according to the World
Psoriasis Day consortium.
·
According to Gulbahar S et al., about 90% of
psoriasis cases is plaque psoriasis, which is characterized by
"plaques", or raised, red areas of skin covered with a silver or
white layer of scale.
·
Psoriasis is considered equally prevalent in
both sexes. However, out of all studies that reported prevalence by sex in
Global report of Psoriasis by World Health Organization, some of them indicate
that psoriasis is more common in men. This issue needs further investigation.
View Report: https://www.delveinsight.com/report-store/plaque-psoriasis-market
Request for free
sample report: https://www.delveinsight.com/sample-request/plaque-psoriasis-market
Scope of the Report
·
The report covers the descriptive overview of
Plaque Psoriasis, explaining its causes, signs and symptoms, pathophysiology,
diagnosis and currently available therapies
·
Comprehensive insight has been provided into the
Plaque Psoriasis epidemiology and treatment in the 7MM
·
Additionally, an all-inclusive account of both
the current and emerging therapies for Plaque Psoriasis are provided, along
with the assessment of new therapies, which will have an impact on the current
treatment landscape
·
A detailed review of Plaque Psoriasis market;
historical and forecasted is included in the report, covering drug outreach in
the 7MM
·
The report provides an edge while developing
business strategies, by understanding trends shaping and driving the global
Plaque Psoriasis market
View Report: https://www.delveinsight.com/report-store/plaque-psoriasis-market
Request for free
sample report: https://www.delveinsight.com/sample-request/plaque-psoriasis-market
Psoriasis
is a common skin condition that speeds up the life cycle of skin cells. It
causes cells to build up rapidly on the surface of the skin. The extra skin
cells form scales and red patches that are itchy and sometimes painful.
According to National Psoriasis Foundation (NPF), plaque
psoriasis is the most common form of psoriasis and appears as raised, red
patches covered with a silvery white buildup of dead skin cells. These patches
or plaques most often show up on the scalp, knees, elbows and lower back. They
are often itchy and painful, and they can crack and bleed.
The characteristic signs and symptoms of psoriasis are small
scaly, red bumps. These bumps generally join together into elevated plaques of
skin and most often are visible on the elbows, knees, and scalp, although any
area of skin can be involved. Frequently, these plaques are quite itchy.
Rarely, most of the patient's skin surface is affected.
·
Bristol-Myers Squibb
·
Dermavant Sciences GmbH
·
Arcutis, Inc.
·
Avillion LLP
·
And Many Others
·
TAZORAC
·
M1095
·
Tapinarof
·
BMS-986165
·
And Many Others
View Report: https://www.delveinsight.com/report-store/plaque-psoriasis-market
Request for free
sample report: https://www.delveinsight.com/sample-request/plaque-psoriasis-market
1. Key Insights
2. Executive Summary
of Plaque Psoriasis
3. Competitive
Intelligence Analysis for Plaque Psoriasis
4. Plaque Psoriasis:
Market Overview at a Glance
4.1. Plaque Psoriasis Total Market Share (%) Distribution in
2017
4.2. Plaque Psoriasis Total Market Share (%) Distribution in
2030
5. Plaque Psoriasis:
Disease Background and Overview
6. Patient Journey
7. Plaque Psoriasis
Epidemiology and Patient Population
8. Treatment
Algorithm, Current Treatment, and Medical Practices
8.1. Plaque Psoriasis Treatment and Management
8.2. Plaque Psoriasis Treatment Algorithm
9. Unmet Needs
10. Key Endpoints of
Plaque Psoriasis Treatment
11. Marketed
Products
List to be continued in report
12. Emerging
Therapies
List to be continued in report
13. Plaque
Psoriasis: Seven Major Market Analysis
13.1. Key Findings
13.2. Plaque Psoriasis Market Size in 7MM
13.3. Plaque Psoriasis Market Size by Therapies in the 7MM
14. Attribute
analysis
15. 7MM: Market
Outlook
16. Access and
Reimbursement Overview of Plaque Psoriasis
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight
Capabilities
22. Disclaimer
23. About
DelveInsight
About DelveInsight
DelveInsight is a premier Business Consulting and Market
Research firm focused exclusively on the life science segment. With a wide
array of smart end-to-end solutions, the firm helps the global Pharmaceutical
and Bio-Tech companies formulate prudent business decisions for
Browse through our vast repository from here.
Media Contact
Company Name: DelveInsight
Business Research LLP
Contact Person: Ankit Nigam
Email: info@delveinsight.com
Phone: +19193216187
City: Albany
State: New York
Country: United States
Website: https://www.delveinsight.com/
Comments
Post a Comment